-+ 0.00%
-+ 0.00%
-+ 0.00%

PASITHEA THERAPEUTICS ANNOUNCES ACTIVATION OF CLINICAL TRIAL SITES IN SOUTH KOREA FOR PHASE 1/1B TRIAL OF PAS-004 IN ADULT NF1 PATIENTS

Reuters·09/16/2025 11:03:00

Please log in to view news